Cover Image
市場調查報告書

族群健康管理 (PHM)的全球市場:市場機會,市場分析,市場佔有率,及未來預測

Global Population Health Management Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 -2023

出版商 Occams Business Research & Consulting Pvt. Ltd. 商品編碼 531948
出版日期 內容資訊 英文 190 Pages
商品交期: 請詢問到貨日
價格
Back to Top
族群健康管理 (PHM)的全球市場:市場機會,市場分析,市場佔有率,及未來預測 Global Population Health Management Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 -2023
出版日期: 2017年07月19日 內容資訊: 英文 190 Pages
簡介

本報告以族群健康管理 (PHM)的全球市場為研究主題,提供市場成長的推動要素,阻礙因素,市場機會,市場競爭情形等總括性檢驗,目前市場方案分析與市場預測。

第1章 序論

  • 摘要整理
  • 市場評估手法

第2章 市場概要

  • 族群健康管理的全球市場:演進與變化
  • 市場定義及範圍
  • 產業結構
  • 相關法規
  • 全體市場分析
    • 主要5項重要的調查結果
    • 前5名市場機會
    • 主要5家公司
    • 前3名競爭策略
  • 市場預算分析
  • 策略性分析
    • 投資 vs. 引進模式
    • 全方位產業分析
    • 波特的五力分析模型
    • Seesaw分析
    • 消費者分析及主要購買標準
  • 市場競爭分析
    • 重要策略與分析
    • 市場佔有率及龍頭企業分析
  • 策略性建議及重要的結論事項
    • 各地區投資機會
    • 對於新用途的市場機會
    • 對最快速成長領域的投資機會

第3章 市場決策要素

  • 市場成長的推動要素
  • 市場成長的阻礙要素
  • 市場機會
  • 市場課題

第4章 市場分類

  • 族群健康管理的全球市場的各構成要素分析
    • 市場定義及範圍
    • 成為決策根據的資料庫及評估手法
    • 市場領域間的比較分析
    • 市場機會矩陣
    • 市場分類
  • 族群健康管理的全球市場的適用各領域分析
    • 市場分類
  • 族群健康管理的全球市場的各管理用設備及網路分析
    • 市場分類
  • 族群健康管理的全球市場的各終端用戶分析
    • 市場分類

第5章 市場競爭情形

  • 主要策略

第6章 族群健康管理的全球市場的各地區分析

  • 地區市場分類
    • 北美
    • 歐洲
    • 亞太地區
    • 其他地區

第7章 主要企業簡介

目錄
Product Code: HHE-6330717

Population health management is the process to collect and analyze clinical data of patient's health care setting. It includes the combination of outcomes assessment and clinical care with healthcare economics. Population health management facilitates providers, patients and insurers to collect, exchange and make proper analysis of patient data by coordinating care and assist effective wellness via evidence-based decision support in clinical care. The global population health management market is growing with a CAGR of around 25% during the forecast period 2016-2023. The drivers leading to the growth of population health management market is executions of the affordable care act in the United States, support of government for the prevention of diseases and adoption of healthcare it, advancement in IT, increasing geriatric population and high burden of chronic diseases. Moreover, the rising focus towards personalized medicine based on analytics and high market potential in emerging economies are some opportunities which leads to the growth prospects of the global population health management market. The major challenge negatively impacting the market is high investments in infrastructure to set up a robust population health management program.

Global population health management market is segmented into 4 major segments which includes component, mode of delivery, application and end-user. On the basis of component type the market is sub segmented into hardware, software and services. On the basis of mode of delivery, it is divided into 4 segments which include web based, cloud based, on premise based and mobile based. The end-user segment consists of 3 sub segments which includes healthcare providers, healthcare payers and government bodies and employer groups. The application segment is divided into patient outreach, hospital readmission reduction, increased patient wellbeing and engagement, no-show rate reduction and Automating Patient-Centered Medical Home (PCMH).

Geographically the population health management market is segmented into North America, Asia Pacific, Europe and rest of the world. North America is the dominating regions across geography due to the growing healthcare expenditure and healthcare cost and rising geriatric population leading to the high prevalence of chronic diseases. However, Asia Pacific is anticipated to grow with highest CAGR owning digitization in healthcare industry and growing healthcare industry in developing nations like India and China.

The key players of the population health management include Cerner Corporation (U.S.), McKesson Corporation (U.S.), All scripts Healthcare Solutions, Inc. (U.S.), Healthagen, LLC. (U.S.), Conifer Health Solutions, OptumHealth (U.S.), Wellcentive, Inc. (U.S), IBM Corporation (U.S.), Epic Corporation, Inc. (U.S.), LLC (U.S.), Health Catalyst, LLC (U.S.), and Verscend Technologies, Inc. (U.S.).

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. EXECUTIVE SUMMARY
  • 1.2. ESTIMATION METHODOLOGY

2. MARKET OVERVIEW

  • 2.1. GLOBAL POPULATION HEALTH MANAGEMENT MARKET: EVOLUTION & TRANSITION
  • 2.2. MARKET DEFINITION AND SCOPE
  • 2.3. INDUSTRY STRUCTURE
  • 2.4. REGULATORY FRAMEWORK
  • 2.5. TOTAL MARKET ANALYSIS
    • 2.5.1. TOP 5 FINDINGS
    • 2.5.2. TOP 5 OPPORTUNITY MARKETS
    • 2.5.3. TOP 5 COMPANIES
    • 2.5.4. TOP 3 COMPETITIVE STRATEGIES
  • 2.6. ESTIMATION ANALYSIS
  • 2.7. STRATEGIC ANALYSIS
    • 2.7.1. INVESTMENT VS. ADOPTION MODEL
    • 2.7.2. 360 DEGREE INDUSTRY ANALYSIS
    • 2.7.3. PORTERS 5 BYCE MODEL
    • 2.7.4. SEE-SAW ANALYSIS
    • 2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
  • 2.8. COMPETITIVE ANALYSIS
    • 2.8.1. KEY STRATEGIES AND ANALYSIS
    • 2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS
  • 2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
    • 2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
    • 2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
    • 2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT

3. MARKET DETERMINANTS

  • 3.1. MARKET DRIVERS
    • 3.1.1. EXECUTIONS OF THE AFFORDABLE CARE ACT IN THE U.S.
    • 3.1.2. SUPPORT OF GOVERNMENT FOR THE PREVENTION OF DISEASES AND ADOPTION OF HEALTHCARE IT
    • 3.1.3. INCREASING GERIATRIC POPULATION AND HIGH BURDEN OF CHRONIC DISEASES
    • 3.1.4. REQUIREMENT FOR AFFORDABLE TREATMENT OPTIONS DUE TO INCREASING HEALTHCARE COSTS
    • 3.1.5. ADVANCEMENT IN IT AND BIG DATA CAPABILITIES
  • 3.2. MARKET RESTRAINTS
    • 3.2.1. ISSUES RELATED TO THE SAFETY OF PATIENT INFORMATION
    • 3.2.2. DEARTH OF SKILLED ANALYST AND DATA MANAGEMENT CAPABILITIES
    • 3.2.3. UNWILLINGNESS TO MIGRATE FROM LEGACY SYSTEMS
  • 3.3. MARKET OPPORTUNITIES
    • 3.3.1. RISING FOCUS TOWARDS VALUE-BASED MEDICINE
    • 3.3.2. FOCUS TOWARDS PERSONALIZED MEDICINE BASED ON ANALYTICS
    • 3.3.3. HIGH MARKET POTENTIAL IN EMERGING ECONOMIES
  • 3.4. MARKET CHALLENGES
    • 3.4.1. HIGH INVESTMENTS IN INFRASTRUCTURE TO SET UP A ROBUST POPULATION HEALTH MANAGEMENT PROGRAM
    • 3.4.2. LACK OF PROPER SYSTEMS FOR THE SMOOTH FUNCTIONING OF PHM PROGRAMS

4. MARKET SEGMENTATION

  • 4.1. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY COMPONENT
    • 4.1.1. MARKET DEFINITION AND SCOPE
    • 4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.1.4. OPPORTUNITY MATRIX
    • 4.1.5. MARKET SEGMENTATION
      • 4.1.5.1. GLOBAL SOFTWARE MARKET
        • 4.1.5.1.1. APPLICATION
        • 4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.1.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.1.5. KEY CONCLUSIONS
      • 4.1.5.2. GLOBAL SERVICES MARKET
        • 4.1.5.2.1. APPLICATION
        • 4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.2.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.2.5. KEY CONCLUSIONS
      • 4.1.5.3. GLOBAL HARDWARE MARKET
        • 4.1.5.3.1. APPLICATION
        • 4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.1.5.3.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.1.5.3.5. KEY CONCLUSIONS
  • 4.2. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY APPLICATIONS
    • 4.2.1. MARKET DEFINITION AND SCOPE
    • 4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.2.4. OPPORTUNITY MATRIX
    • 4.2.5. MARKET SEGMENTATION
      • 4.2.5.1. GLOBAL PATIENT OUTREACH MARKET
        • 4.2.5.1.1. APPLICATION
        • 4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.1.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.1.5. KEY CONCLUSIONS
      • 4.2.5.2. GLOBAL HOSPITAL READMISSIOPN REDUCTION MARKET
        • 4.2.5.2.1. APPLICATION
        • 4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.2.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.2.5. KEY CONCLUSIONS
      • 4.2.5.3. GLOBAL NO SHOW RATE REDUCTION MARKET
        • 4.2.5.3.1. APPLICATION
        • 4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.3.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.3.5. KEY CONCLUSIONS
      • 4.2.5.4. GLOBAL AUTOMATING PATIENT CENTER MEDICAL HOME MARKET
        • 4.2.5.4.1. APPLICATION
        • 4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.4.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.4.5. KEY CONCLUSIONS
      • 4.2.5.5. GLOBAL PATIENT WELL BEING AND ENGAGEMENT MARKET
        • 4.2.5.5.1. APPLICATION
        • 4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.2.5.5.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.2.5.5.5. KEY CONCLUSIONS
  • 4.3. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY MODE OF DELIVERY
    • 4.3.1. MARKET DEFINITION AND SCOPE
    • 4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.3.4. OPPORTUNITY MATRIX
    • 4.3.5. MARKET SEGMENTATION
      • 4.3.5.1. GLOBAL WEB BASED MARKET
        • 4.3.5.1.1. APPLICATION
        • 4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.1.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.1.5. KEY CONCLUSIONS
      • 4.3.5.2. GLOBAL CLOUD BASED MARKET
        • 4.3.5.2.1. APPLICATION
        • 4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.2.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.3.5.2.5. KEY CONCLUSIONS
      • 4.3.5.3. GLOBAL ON PREMISE BASED MARKET
        • 4.3.5.3.1. APPLICATION
        • 4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.3.4. TOP KEY PLAYERS & KEY PRODUCTS
      • 4.3.5.4. GLOBAL MOBILE BASED MARKET
        • 4.3.5.4.1. APPLICATION
        • 4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.3.5.4.4. TOP KEY PLAYERS & KEY PRODUCTS
  • 4.4. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY ENDUSER
    • 4.4.1. MARKET DEFINITION AND SCOPE
    • 4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
    • 4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
    • 4.4.4. OPPORTUNITY MATRIX
    • 4.4.5. MARKET SEGMENTATION
      • 4.4.5.1. GLOBAL HEALTHCARE PROVIDERS MARKET
        • 4.4.5.1.1. APPLICATION
        • 4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.1.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.1.5. KEY CONCLUSIONS
      • 4.4.5.2. GLOBAL HEALTHCARE PAYERS MARKET
        • 4.4.5.2.1. APPLICATION
        • 4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.2.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.2.5. KEY CONCLUSIONS
      • 4.4.5.3. GLOBAL EMPLOYERS GROUP MARKET
        • 4.4.5.3.1. APPLICATION
        • 4.4.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.3.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.3.5. KEY CONCLUSIONS
      • 4.4.5.4. GLOBAL GOVERNMENT BODIES MARKET
        • 4.4.5.4.1. APPLICATION
        • 4.4.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
        • 4.4.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
        • 4.4.5.4.4. TOP KEY PLAYERS & KEY PRODUCTS
        • 4.4.5.4.5. KEY CONCLUSIONS

5. COMPETITIVE LANDSCAPE

  • 5.1. KEY STRATEGIES
    • 5.1.1. LIST OF MERGERS & ACQUISITION
    • 5.1.2. LIST OF JOINT VENTURES
    • 5.1.3. LIST OF PRODUCT LAUNCHES
    • 5.1.4. LIST OF PARTNERSHIPS

6. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY REGION

  • 6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
  • 6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
  • 6.3. OPPORTUNITY MATRIX
  • 6.4. GEOGRAPHIC SEGMENTATION
    • 6.4.1. NORTH AMERICA
      • 6.4.1.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.1.2. TOP COUNTRY ANALYSIS
        • 6.4.1.2.1. U.S.
          • 6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.1.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.1.3. KEY CONCLUSIONS
        • 6.4.1.2.2. CANADA
          • 6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
          • 6.4.1.2.2.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.1.2.2.3. KEY CONCLUSIONS
    • 6.4.2. EUROPE
      • 6.4.2.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.2.2. TOP COUNTRY ANALYSIS
        • 6.4.2.2.1. UK
          • 6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.1.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.1.3. KEY CONCLUSIONS
        • 6.4.2.2.2. FRANCE
          • 6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.2.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.2.3. KEY CONCLUSIONS
        • 6.4.2.2.3. GERMANY
          • 6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.3.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.3.3. KEY CONCLUSIONS
        • 6.4.2.2.4. REST OF EUROPE
          • 6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.2.2.4.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.2.2.4.3. KEY CONCLUSIONS
    • 6.4.3. ASIA PACIFIC
      • 6.4.3.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.3.2. TOP COUNTRY ANALYSIS
        • 6.4.3.2.1. CHINA
          • 6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.1.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.1.3. KEY CONCLUSIONS
        • 6.4.3.2.2. INDIA
          • 6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.2.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.2.3. KEY CONCLUSIONS
        • 6.4.3.2.3. JAPAN
          • 6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.3.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.3.3. KEY CONCLUSIONS
        • 6.4.3.2.4. REST OF ASIA PACIFIC
          • 6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.3.2.4.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.3.2.4.3. KEY CONCLUSIONS
    • 6.4.4. ROW
      • 6.4.4.1. INDUSTRY APPLICATION ANALYSIS
      • 6.4.4.2. TOP COUNTRY ANALYSIS
        • 6.4.4.2.1. LATIN AMERICA
          • 6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.4.2.1.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.1.3. KEY CONCLUSIONS
        • 6.4.4.2.2. MIDDLE EAST & AFRICA
          • 6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($ MILLION)
          • 6.4.4.2.2.2. TOP KEY PLAYERS & KEY PRODUCTS
          • 6.4.4.2.2.3. KEY CONCLUSIONS

7. COMPANY PROFILES

  • 7.1. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC
    • 7.1.1. OVERVIEW
    • 7.1.2. PRODUCT PORTFOLIO
    • 7.1.3. KEY INNOVATION/FOCUS SECTOR
    • 7.1.4. STRATEGIC INITIATIVES
    • 7.1.5. SCOT ANALYSIS
    • 7.1.6. STRATEGIC ANALYSIS
  • 7.2. ACCENTURE
    • 7.2.1. OVERVIEW
    • 7.2.2. PRODUCT PORTFOLIO
    • 7.2.3. KEY INNOVATION/FOCUS SECTOR
    • 7.2.4. STRATEGIC INITIATIVES
    • 7.2.5. SCOT ANALYSIS
    • 7.2.6. STRATEGIC ANALYSIS
  • 7.3. CONIFER HEALTH SOLUTIONS, LLC
    • 7.3.1. OVERVIEW
    • 7.3.2. PRODUCT PORTFOLIO
    • 7.3.3. KEY INNOVATION/FOCUS SECTOR
    • 7.3.4. STRATEGIC INITIATIVES
    • 7.3.5. SCOT ANALYSIS
    • 7.3.6. STRATEGIC ANALYSIS
  • 7.4. . CERNER CORPORATION
    • 7.4.1. OVERVIEW
    • 7.4.2. PRODUCT PORTFOLIO
    • 7.4.3. KEY INNOVATION/FOCUS SECTOR
    • 7.4.4. STRATEGIC INITIATIVES
    • 7.4.5. SCOT ANALYSIS
    • 7.4.6. STRATEGIC ANALYSIS
  • 7.5. DELLOITE
    • 7.5.1. OVERVIEW
    • 7.5.2. PRODUCT PORTFOLIO
    • 7.5.3. KEY INNOVATION/FOCUS SECTOR
    • 7.5.4. STRATEGIC INITIATIVES
    • 7.5.5. SCOT ANALYSIS
    • 7.5.6. STRATEGIC ANALYSIS
  • 7.6. EPIC CORPORATION, INC.
    • 7.6.1. OVERVIEW
    • 7.6.2. PRODUCT PORTFOLIO
    • 7.6.3. KEY INNOVATION/FOCUS SECTOR
    • 7.6.4. STRATEGIC INITIATIVES
    • 7.6.5. SCOT ANALYSIS
    • 7.6.6. STRATEGIC ANALYSIS
  • 7.7. HEALTHAGEN, LLC (A DIVISION OF AETNA, INC.)
    • 7.7.1. OVERVIEW
    • 7.7.2. PRODUCT PORTFOLIO
    • 7.7.3. KEY INNOVATION/FOCUS SECTOR
    • 7.7.4. STRATEGIC INITIATIVES
    • 7.7.5. SCOT ANALYSIS
    • 7.7.6. STRATEGIC ANALYSIS
  • 7.8. HEALTH CATALYST, LLC
    • 7.8.1. OVERVIEW
    • 7.8.2. PRODUCT PORTFOLIO
    • 7.8.3. KEY INNOVATION/FOCUS SECTOR
    • 7.8.4. STRATEGIC INITIATIVES
    • 7.8.5. SCOT ANALYSIS
    • 7.8.6. STRATEGIC ANALYSIS
  • 7.9. IBM Corporation
    • 7.9.1. OVERVIEW
    • 7.9.2. PRODUCT PORTFOLIO
    • 7.9.3. KEY INNOVATION/FOCUS SECTOR
    • 7.9.4. STRATEGIC INITIATIVES
    • 7.9.5. SCOT ANALYSIS
    • 7.9.6. STRATEGIC ANALYSIS
  • 7.10. MEDECISION
    • 7.10.1. OVERVIEW
    • 7.10.2. PRODUCT PORTFOLIO
    • 7.10.3. KEY INNOVATION/FOCUS SECTOR
    • 7.10.4. STRATEGIC INITIATIVES
    • 7.10.5. SCOT ANALYSIS
    • 7.10.6. STRATEGIC ANALYSIS
  • 7.11. MCKESSON CORPORATION
    • 7.11.1. OVERVIEW
    • 7.11.2. PRODUCT PORTFOLIO
    • 7.11.3. KEY INNOVATION/FOCUS SECTOR
    • 7.11.4. STRATEGIC INITIATIVES
    • 7.11.5. SCOT ANALYSIS
    • 7.11.6. STRATEGIC ANALYSIS
  • 7.12. PHYTEL
    • 7.12.1. OVERVIEW
    • 7.12.2. PRODUCT PORTFOLIO
    • 7.12.3. KEY INNOVATION/FOCUS SECTOR
    • 7.12.4. STRATEGIC INITIATIVES
    • 7.12.5. SCOT ANALYSIS
    • 7.12.6. STRATEGIC ANALYSIS
  • 7.13. OPTUMHEALTH (UNITEDHEALTH GROUP, INC.)
    • 7.13.1. OVERVIEW
    • 7.13.2. PRODUCT PORTFOLIO
    • 7.13.3. KEY INNOVATION/FOCUS SECTOR
    • 7.13.4. STRATEGIC INITIATIVES
    • 7.13.5. SCOT ANALYSIS
    • 7.13.6. STRATEGIC ANALYSIS
  • 7.14. WELLCENTIVE, INC. (A SUBSIDIARY OF ROYAL PHILIPS)
    • 7.14.1. OVERVIEW
    • 7.14.2. PRODUCT PORTFOLIO
    • 7.14.3. KEY INNOVATION/FOCUS SECTOR
    • 7.14.4. STRATEGIC INITIATIVES
    • 7.14.5. SCOT ANALYSIS
    • 7.14.6. STRATEGIC ANALYSIS
  • 7.15. VERSCEND TECHNOLOGIES, INC.
    • 7.15.1. OVERVIEW
    • 7.15.2. PRODUCT PORTFOLIO
    • 7.15.3. KEY INNOVATION/FOCUS SECTOR
    • 7.15.4. STRATEGIC INITIATIVES
    • 7.15.5. SCOT ANALYSIS
    • 7.15.6. STRATEGIC ANALYSIS

LIST OF TABLES

  • Table 1. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY COMPONENET 2014-2023 ($ MILLION)
  • Table 2. GLOBAL SOFTWARE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 3. GLOBAL SERVICES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 4. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY APPLICATIONS 2014-2023 ($ MILLION)
  • Table 5. GLOBAL PATIENT OUT REACH MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 6. GLOBAL HOSPITAL READMISSION REDUCTION MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 7. GLOBAL NO SHOE RATE REDUCTION BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 8. GLOBAL AUTOMATING PATIENT CENTER MEDICAL HOMEMARKET BY SENSORS 2014-2023 ($ MILLION)
  • Table 9. GLOBAL INCREASED WELL BEING AND ENGAGEMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 10. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY MODE OF DELIVERY 2014-2023 ($ MILLION)
  • Table 11. GLOBAL WEB BASED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 12. GLOBAL CLOUD BASED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 13. GLOBAL MOBILE BASED MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 14. GLOBAL ON PREMISE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 15. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY ENDUSER 2014-2023 ($ MILLION)
  • Table 16. GLOBAL HEALTHCARE PROVIDERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 17. GLOBAL HEALTHCARE PAYERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 18. GLOBAL EMPLOYER GROUPS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 19. GLOBAL GOVERNMENT BODIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
  • Table 20. NORTH AMERICA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Table 21. EUROPE POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Table 22. ASIA PACIFIC POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Table 23. REST OF THE WORLD POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)

LIST OF FIGURES

  • Figure 1. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY SOFTWARE 2014-2023 ($ MILLION)
  • Figure 2. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY HARDWARE 2014-2023 ($ MILLION)
  • Figure 3. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY SERVICES 2014-2023 ($ MILLION)
  • Figure 4. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY PATIENT OUT REACH 2014-2023 ($ MILLION)
  • Figure 5. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY HOSPITAL RE-ADMISSION REDUCTION 2014-2023 ($ MILLION)
  • Figure 6. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY NO SHOW RATE REDUCTION 2014-2023 ($ MILLION)
  • Figure 7. GLOBAL POPULATION HEALTH MANAGEMENT MARKET AUTOMATING PATIENT CENTERED MEDICAL HOME 2014-2023 ($ MILLION)
  • Figure 8. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY INCREASED PATIENT WELLBENG AND ENGAGEMENT 2014-2023 ($ MILLION)
  • Figure 9. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY WEB BASED 2014-2023 ($ MILLION)
  • Figure 10. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY MOBIOLE BASED 2014-2023 ($ MILLION)
  • Figure 11. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY CLOUD BASED 2014-2023 ($ MILLION)
  • Figure 12. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY ON PREMISE BASED 2014-2023 ($ MILLION)
  • Figure 13. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY HEALTHCARE PROVIDERS 2014-2023 ($ MILLION)
  • Figure 14. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY HEALTHCARE PAYERS 2014-2023 ($ MILLION)
  • Figure 15. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY EMPLOYERS GROUPS 2014-2023 ($ MILLION)
  • Figure 16. GLOBAL POPULATION HEALTH MANAGEMENT MARKET BY GOVERNMENT BODIES 2014-2023 ($ MILLION)
  • Figure 17. UNITED STATES (U.S.) POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 18. CANADA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 19. UNITED KINGDOM (UK) POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 20. FRANCE POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 21. GERMANY POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 22. SPAIN POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 23. ITALY POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 24. ROE POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 25. INDIA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 26. CHINA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 27. JAPAN POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 28. KOREA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 29. AUSTRALIA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 30. ROW APAC POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 31. LATIN AMERICA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
  • Figure 32. MENA POPULATION HEALTH MANAGEMENT MARKET 2014-2023 ($ MILLION)
Back to Top